Albuminuria independently predicts cardiovascular and all-cause mortality in a middle-aged and elderly Chinese population

被引:17
作者
Chen, Ying-Ying [1 ]
Li, Yan-Yan [1 ]
Lu, Yan-Hui [1 ]
Dou, Jing-Tao [1 ]
Wang, Shu-Yu [2 ]
Lu, Ju-Ming [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China
[2] Inst Beijing Hypertens League, Beijing, Peoples R China
关键词
Macroalbuminuria; microalbuminuria; cardiovascular disease; mortality; China; GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; GENERAL-POPULATION; ENDOTHELIAL DYSFUNCTION; RENAL-FUNCTION; MICROALBUMINURIA; COHORTS; INDIVIDUALS; ASSOCIATION; DISEASE;
D O I
10.3109/00365513.2012.661071
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim. To investigate the relationship between albuminuria and mortality in a middle-aged-to-elderly Chinese population. Methods. A total of 2,344 individuals aged over 40 in the same district were interviewed and followed up for 4 years. Information on survival or cause of death was recorded. A total of 2,181 participants with detailed information were finally recruited. Baseline overnight urine samples were obtained to measure urinary albumin and creatinine. The urinary albumin excretion rate was expressed as albumin-to-creatinine ratio (ACR). Participants were divided into three groups, according to their ACR: normoalbuminuria (ACR < 30 mg/g), microalbuminuria (>= 30 - <300 mg/g ACR) and macroalbuminuria (ACR < 300 mg/g). The Cox proportional hazard model was used to analyze the relationships between albuminuria and cardiovascular and all-cause mortalities. Results. Seventy-seven deaths with known causes were registered. The prevalences of microalbuminuria and macroalbuminuria at baseline were 8.3% and 1.6%, respectively. Cardiovascular mortalities in the normoalbuminuria, microalbuminuria and macroalbuminuria groups were 2.4, 11.0, and 36.8/1,000 person years (pyrs) respectively, and all-cause mortalities were 6.9, 20.6, and 58.8/1,000 pyrs. After adjusting for confounding factors, the relative risks (RR) of cardiovascular mortality were 2.72 (95% CI, 1.06-4.20) in the microalbuminuria group, and 4.87 (95% CI, 2.46-9.45) in the macroalbuminuria group. Adjusted RRs for all-cause mortality were 2.01 (95% CI, 0.96-4.77) and 3.76 (95% CI, 1.52-7.15) in the two groups, respectively. Conclusion. Albuminuria is a useful predictor of cardiovascular mortality and all-cause mortality in the general population.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 14 条
[1]   Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts [J].
Astor, Brad C. ;
Matsushita, Kunihiro ;
Gansevoort, Ron T. ;
van der Velde, Marije ;
Woodward, Mark ;
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef .
KIDNEY INTERNATIONAL, 2011, 79 (12) :1331-1340
[2]   Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes -: Results and projections from the Steno-2 study [J].
Gaede, Peter ;
Valentine, William J. ;
Palmer, Andrew J. ;
Tucker, Daniel M. D. ;
Lammert, Morten ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
DIABETES CARE, 2008, 31 (08) :1510-1515
[3]   Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[4]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[5]   Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria [J].
Jager, A ;
van Hinsbergh, VWM ;
Kostense, PJ ;
Emeis, JJ ;
Nijpels, G ;
Dekker, JM ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) :529-536
[6]   The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality [J].
Klausen, K. P. ;
Parving, H.-H. ;
Scharling, H. ;
Jensen, J. S. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (04) :470-478
[7]   Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus [J].
Kubisz, Peter ;
Chudy, Peter ;
Stasko, Jan ;
Galajda, Peter ;
Holly, Pavol ;
Vysehradsky, Robert ;
Mokan, Marian .
ACTA DIABETOLOGICA, 2010, 47 (02) :119-124
[8]   Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis [J].
Matsushita, Kunihiro ;
van der Velde, Marije ;
Astor, Brad C. ;
Woodward, Mark ;
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef ;
Gansevoort, Ron T. .
LANCET, 2010, 375 (9731) :2073-2081
[9]   Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study [J].
Persson, Frederik ;
Rossing, Peter ;
Hovind, Peter ;
Stehouwer, Coen D. A. ;
Schalkwijk, Casper G. ;
Tarnow, Lise ;
Parving, Hans-Henrik .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (08) :731-738
[10]   Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals:: A 4.4-year follow-up study.: The Nord-Trondelag Health Study (HUNT), Norway [J].
Romundstad, S ;
Holmen, J ;
Kvenild, K ;
Hallan, H ;
Ellekjær, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03) :466-473